financetom
Business
financetom
/
Business
/
Microsoft offers to boost European governments' cybersecurity for free
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft offers to boost European governments' cybersecurity for free
Jun 4, 2025 4:11 AM

By Supantha Mukherjee

STOCKHOLM, June 4 (Reuters) - Microsoft ( MSFT ) is

offering free of charge to European governments a cybersecurity

programme, launched on Wednesday, to bolster their defences

against cyber threats, including those enhanced by artificial

intelligence, it said.

After a surge in cyberattacks in Europe, many linked to

state-sponsored actors from China, Iran, North Korea and Russia,

the programme aims to boost intelligence-sharing on AI-based

threats and help to prevent and disrupt attacks.

"If we can bring more to Europe of what we have developed in

the United States, that will strengthen cybersecurity protection

for more European institutions," Microsoft ( MSFT ) President Brad Smith

told Reuters in an interview.

"You're going to see other things we are doing later in the

month."

Increasingly, attackers employ generative AI to amplify the

scale and impact of their operations that range from disrupting

critical infrastructure to spreading disinformation.

Although malicious actors have weaponised AI, Smith said AI

also offered defensive tools.

"We don't feel that we have seen AI that has evaded our

ability to detect the use of AI or the threats more broadly,"

Smith said.

"Our goal needs to be to keep AI advancing as a defensive

tool faster than it advances as an offensive weapon," he said.

Microsoft ( MSFT ) tracks any malicious use of AI models it releases

and prevents known cybercriminals from using its AI products.

AI-driven deepfakes have included a portrayal of Ukrainian

President Volodymyr Zelenskiy capitulating to Russian demands in

2022 and a fake audio recording in 2023 that influenced the

Slovakian election.

Smith said so far audio had been easier to fake than video.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MOVES-Bank of America set to appoint Vikram Sahu as new country head for India
MOVES-Bank of America set to appoint Vikram Sahu as new country head for India
Mar 24, 2025
MUMBAI, March 24 (Reuters) - Bank of America Corp ( BAC ) is set to appoint Vikram Sahu as the new country executive for its India business, according to a memo reviewed by Reuters. Sahu, who is currently head of global equity research based out of New York, will replace Kaku Nakhate as the India country executive. Sahu will move...
23andMe Begins Chapter 11 Bankruptcy to Sell Off Assets
23andMe Begins Chapter 11 Bankruptcy to Sell Off Assets
Mar 24, 2025
04:35 AM EDT, 03/24/2025 (MT Newswires) -- 23andMe ME) said Sunday it has begun voluntary Chapter 11 bankruptcy proceedings to facilitate a sale. The genetics testing and genealogy company said it plans to continue operating and safeguard customer data during the process. 23andMe said it is seeking court authorization to sell all of its assets through a chapter 11 plan...
SEALSQ to Acquire 30% Stake in WeCanGroup
SEALSQ to Acquire 30% Stake in WeCanGroup
Mar 24, 2025
04:27 AM EDT, 03/24/2025 (MT Newswires) -- SEALSQ ( LAES ) has agreed to acquire a 30% equity interest in blockchain technology firm WeCanGroup, the companies said Monday. SEALSQ ( LAES ), its parent WISeKey, and WeCanGroup will integrate their Web 3.0 and post-quantum cryptographic technologies under the terms of the deal. SEALSQ ( LAES ) shares were up 6.7%...
Opthea's Phase 3 Eye Therapy Trial Fails to Meet Primary Endpoint
Opthea's Phase 3 Eye Therapy Trial Fails to Meet Primary Endpoint
Mar 24, 2025
04:21 AM EDT, 03/24/2025 (MT Newswires) -- Opthea ( OPT ) said Monday the phase 3 study of its experimental drug, sozinibercept in combination with aflibercept to treat patients with wet age-related macular degeneration, did not meet its primary endpoint. Following the results, Opthea ( OPT ) said it is evaluating its obligations under its development funding agreement with investors,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved